1. Brunton L, Chabner B, Knollmann B. Gilman and Goodman: the pharmacological basis of therapeutics. 12a. Ed. Chapter 43: endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia. New York: McGrawHill; 2011.
2. General Health Council. Federal Government. General Practice Guide. Diagnosis, ambulatory control goals, oportune reference of diabetes mellitus type 2 in adults in first level of attention. SS-093-0.CENETEC, 2013.
3. US Food and Drug Administration. RIOMET® monograph. 2016.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021591s004lbl.pdf
. Accessed Apr 2016.
4. Scheen A. Clinical Pharmacokinetic of metformin. Clin Pharmacokinet. 1996;30:359–71
5. Alemón R, Chávez J, Ramírez B, Rivera L, García R. Estabilidad fisicoquímica de tres marcas genéricas de metformina en solución. Acta Pediátr México. 2014;35:104–10.